Oncology
HERTI 150MG INJ
Trastuzumab 150 mg
HER2-targeted antibody for HER2-positive breast and gastric cancer.
- Composition
- Trastuzumab
- Strength
- 150 mg
- Dosage form
- Injection
- Pack size
- As per quotation
- Therapeutic area
- Oncology
- Documents
- COA, COPP & more on request
- Minimum order
- As per quotation
- Product code
- AG-1579
HERTI 150MG INJ contains Trastuzumab 150 mg. HER2-targeted antibody for HER2-positive breast and gastric cancer. It is supplied as injection. Anzora Global is a pharmaceutical exporter, importer and wholesaler based in Nagpur, India, supplying oncology products to licensed importers, distributors, hospitals and healthcare programmes worldwide. Certificates of analysis, COPP and other export documents can be provided on request. Contact us on WhatsApp or email for pricing, availability and minimum order quantity.